EMA — authorised 13 October 2021
- Status: approved
EMA authorised Koselugo on 13 October 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 13 October 2021.
ASTRAZENECA LP is the originator. The local marketing authorisation holder may differ — check the official source linked above.